These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29171944)

  • 21. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
    Magee AG; Makhecha S; Bentley S
    Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association.
    Nicholson BP; Atchison E; Idris AA; Bakri SJ
    Surv Ophthalmol; 2018; 63(1):1-8. PubMed ID: 28673727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of central serous chorioretinopathy to polypoidal choroidal vasculopathy.
    Yang LH; Jonas JB; Wei WB
    Acta Ophthalmol; 2015 Sep; 93(6):e512-4. PubMed ID: 25778984
    [No Abstract]   [Full Text] [Related]  

  • 27. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.
    Kim SW; Oh J; Kwon SS; Yoo J; Huh K
    Retina; 2011 Oct; 31(9):1904-11. PubMed ID: 21878855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography.
    Vance SK; Imamura Y; Freund KB
    Retina; 2011 Feb; 31(2):332-5. PubMed ID: 20975620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A; Daruich A; Zola M; Behar-Cohen F
    Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central serous chorioretinopathy probably associated with isotretinoin in a keratoconus patient.
    Buyuktortop N; Onaran Z; Özkal F; Yumusak E; Karabulut AA
    Can J Ophthalmol; 2018 Aug; 53(4):e162-e165. PubMed ID: 30119816
    [No Abstract]   [Full Text] [Related]  

  • 33. Low luminance visual acuity in patients with central serous chorioretinopathy.
    Fujita K; Shinoda K; Matsumoto CS; Imamura Y; Mizutani Y; Tanaka E; Mizota A; Oda K; Yuzawa M
    Clin Exp Optom; 2013 Jan; 96(1):100-5. PubMed ID: 22963010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.
    Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK
    JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
    Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
    Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases.
    Valls Pascual E; Martínez-Costa L; Santander F
    BMC Musculoskelet Disord; 2015 Dec; 16():378. PubMed ID: 26638151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central serous chorioretinopathy following medial transposition of split lateral rectus muscle for complete oculomotor nerve palsy.
    Sorenson R; Soni A
    J AAPOS; 2017 Apr; 21(2):161-162. PubMed ID: 28017901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
    Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
    Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Breazzano et al: Prospective Impact of Sildenafil on Chronic Central Serous Chorioretinopathy (Ophthalmology Retina. 2020;4:1119-1123).
    Arora S; Arora T
    Ophthalmol Retina; 2021 Jul; 5(7):e7. PubMed ID: 34243973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.